Abstract

Objective: To determine the acute effect of low and high-dose BA trials on maximal aerobic speed (MAS) in endurance athletes. We hypothesized that high doses of BA have a greater effect than low doses, both compared to baseline. Material and Methods: Twelve male endurance athletes volunteered for the study (age = 21.8 ± 2.37 years, weight = 69.8 ± 4.36 kg, height = 174 ± 5.45 cm, maximal oxygen uptake = 59.6 ± 3.77 mLO2·kg?1·min?1). The experimental design applied was randomized cross-over, double-blind. Treatment included three 6-minute run tests (6-MRT), the first as a baseline, then randomized 6-MRT with low (30 mg·kg?1) and high (45 mg·kg?1) dose BA trials. The 6-MRTs were separated by 72 hours. The main variable of the study was the distance (m) performed in the 6-MRT. Differences between tests were established through ANOVA and Tukey’s multiple comparison tests (p < 0.05). Results: The analysis showed significant differences between baseline and both doses (p < 0.001). No significant differences were observed between low and high-dose BA trials (p > 0.05). Conclusion: Both 30 and 45 mg·kg?1 of BA increased physical performance at maximal aerobic speed in endurance athletes. The acute intake formats described in the present investigation may be helpful for endurance athletes training and competing in aerobic-anaerobic transition zones. © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC.